0 280

Cited 0 times in

Cited 0 times in

Shifting trends in bloodstream infection-causing microorganisms and their clinical impact in patients with haematologic malignancies in South Korea: A propensity score-matched study

DC Field Value Language
dc.contributor.authorChoi, Heekang-
dc.contributor.authorChoi, Min Hyuk-
dc.contributor.authorKim, Dokyun-
dc.contributor.authorLee, Kyoung Hwa-
dc.contributor.authorJeong, Seok Hoon-
dc.date.accessioned2024-10-04T02:01:21Z-
dc.date.available2024-10-04T02:01:21Z-
dc.date.created2025-06-25-
dc.date.issued2024-08-
dc.identifier.issn0924-8579-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/200372-
dc.description.abstractBackground: This study aimed to identify recent trends in the epidemiology of bloodstream infection (BSI)-causing microorganisms among patients with haematologic malignancies (HMs) between 2011 and 2021, and to determine their impact on patient outcomes. Methods: This retrospective study included 6792 patients with HMs, of whom 1308 (19.3%) developed BSI within 1 y of diagnosis. The incidence of BSI-causing microorganisms was determined, and a propensity score-matched study was performed to identify risk factors for 28-d all-cause mortality in patients with HM. Results: A total of 6792 patients with HMs were enrolled. The cumulative incidence of BSI and neutropenia was significantly higher in the acute myeloid leukaemia and acute lymphoblastic leukaemia groups compared to other groups, and neutropenia and type of HMs were risk factors for the development of BSI. The annual incidence of coagulase-negative staphylococci (CoNS)-BSI decreased significantly ( P < 0.001), whereas Klebsiella pneumoniae- BSI increased ( P = 0.01). Carbapenem nonsusceptibility rates in K. pneumoniae isolates increased from 0.0% to 76.5% ( P < 0.001). BSI caused by K. pneumoniae (adjusted odds ratio 2.17; 95% confidence interval 1.12-4.21) was associated with higher 28-d all-cause mortality compared to that caused by CoNS (adjusted odds ratio 0.86; 95% confidence interval 0.48-1.55). Conclusion: The pathogenic spectrum of BSI-causing bacteria in patients with HMs gradually shifted from Gram-positive to Gram-negative, especially from CoNS to K. pneumoniae . Considering that K. pneumoniae BSI had a significantly higher 28-d mortality rate than CoNS-BSI, this evolving trend could adversely impact the clinical outcomes of patients with HMs. (c) 2024 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier Science Publishers-
dc.relation.isPartOfINTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS-
dc.relation.isPartOfINTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleShifting trends in bloodstream infection-causing microorganisms and their clinical impact in patients with haematologic malignancies in South Korea: A propensity score-matched study-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Laboratory Medicine (진단검사의학교실)-
dc.contributor.googleauthorChoi, Heekang-
dc.contributor.googleauthorChoi, Min Hyuk-
dc.contributor.googleauthorKim, Dokyun-
dc.contributor.googleauthorLee, Kyoung Hwa-
dc.contributor.googleauthorJeong, Seok Hoon-
dc.identifier.doi10.1016/j.ijantimicag.2024.107212-
dc.relation.journalcodeJ01088-
dc.identifier.eissn1872-7913-
dc.identifier.pmid38795932-
dc.subject.keywordHaematologic malignancy-
dc.subject.keywordBloodstream infection-
dc.subject.keywordRisk assessment-
dc.subject.keywordAntimicrobial resistance-
dc.subject.keywordCarbapenem resistance-
dc.contributor.alternativeNameKim, Dokyun-
dc.contributor.affiliatedAuthorChoi, Heekang-
dc.contributor.affiliatedAuthorChoi, Min Hyuk-
dc.contributor.affiliatedAuthorKim, Dokyun-
dc.contributor.affiliatedAuthorLee, Kyoung Hwa-
dc.contributor.affiliatedAuthorJeong, Seok Hoon-
dc.identifier.scopusid2-s2.0-85196319150-
dc.identifier.wosid001335088800001-
dc.citation.volume64-
dc.citation.number2-
dc.identifier.bibliographicCitationINTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, Vol.64(2), 2024-08-
dc.identifier.rimsid87106-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorHaematologic malignancy-
dc.subject.keywordAuthorBloodstream infection-
dc.subject.keywordAuthorRisk assessment-
dc.subject.keywordAuthorAntimicrobial resistance-
dc.subject.keywordAuthorCarbapenem resistance-
dc.subject.keywordPlusNEUTROPENIC PATIENTS-
dc.subject.keywordPlusEPIDEMIOLOGY-
dc.subject.keywordPlusBACTEREMIA-
dc.subject.keywordPlusRESISTANCE-
dc.subject.keywordPlusCANCER-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryInfectious Diseases-
dc.relation.journalWebOfScienceCategoryMicrobiology-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.relation.journalResearchAreaInfectious Diseases-
dc.relation.journalResearchAreaMicrobiology-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.identifier.articleno107212-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Laboratory Medicine (진단검사의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.